• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

儿童和成人肥大细胞增多症:临床疾病异质性。

Mastocytosis in children and adults: clinical disease heterogeneity.

机构信息

Department of Dermatology, Venereology and Allergology, Medical University of Gdansk, Poland.

出版信息

Arch Med Sci. 2012 Jul 4;8(3):533-41. doi: 10.5114/aoms.2012.29409.

DOI:10.5114/aoms.2012.29409
PMID:22852012
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3400919/
Abstract

Mastocytosis is a clonal disease of the hematopoietic stem cell. The condition consists of a heterogeneous group of disorders characterized by a pathological accumulation of mast cells in tissues including the skin, bone marrow, liver, spleen and the lymph nodes. Mastocytosis is a rare disease which occurs both in children and adults. Childhood onset mastocytosis is usually cutaneous and transient while in adults the condition commonly progresses to a systemic form. The heterogeneity of clinical presentation of mastocytosis is typically related to the tissue mast cell burden, symptoms due to the release of mast cell mediators, the type of skin lesions, the patient's age at the onset and associated haematological disorders. Therefore, a multidisciplinary approach is recommended. The present article provides an overview of clinical symptoms, diagnostic criteria and treatment of mastocytosis to facilitate the diagnosis and management of mastocytosis patients in clinical practice.

摘要

肥大细胞增多症是造血干细胞的克隆性疾病。其特征为组织中肥大细胞病理性堆积,包括皮肤、骨髓、肝、脾、淋巴结等,由一组异质性疾病组成。肥大细胞增多症为罕见疾病,可发生于儿童及成人。儿童发病的肥大细胞增多症通常为皮肤型且为一过性,而在成人,该疾病通常进展为系统性疾病。肥大细胞增多症的临床表现异质性通常与组织中肥大细胞负荷、肥大细胞介质释放引起的症状、皮肤病变类型、发病时患者年龄以及相关血液学疾病相关。因此,推荐采用多学科方法。本文概述了肥大细胞增多症的临床表现、诊断标准和治疗方法,旨在促进肥大细胞增多症患者的临床诊断和管理。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd40/3400919/b92f4274c26a/AMS-8-18986-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd40/3400919/412adce2d83f/AMS-8-18986-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd40/3400919/cfe1f5f67f23/AMS-8-18986-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd40/3400919/801f622f72e2/AMS-8-18986-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd40/3400919/97485637c80d/AMS-8-18986-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd40/3400919/b92f4274c26a/AMS-8-18986-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd40/3400919/412adce2d83f/AMS-8-18986-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd40/3400919/cfe1f5f67f23/AMS-8-18986-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd40/3400919/801f622f72e2/AMS-8-18986-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd40/3400919/97485637c80d/AMS-8-18986-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd40/3400919/b92f4274c26a/AMS-8-18986-g005.jpg

相似文献

1
Mastocytosis in children and adults: clinical disease heterogeneity.儿童和成人肥大细胞增多症:临床疾病异质性。
Arch Med Sci. 2012 Jul 4;8(3):533-41. doi: 10.5114/aoms.2012.29409.
2
Diagnostic criteria and classification of mastocytosis: a consensus proposal.肥大细胞增多症的诊断标准与分类:一项共识提议。
Leuk Res. 2001 Jul;25(7):603-25. doi: 10.1016/s0145-2126(01)00038-8.
3
[Systemic mastocytosis. A review of current diagnostic and therapeutic approaches].[系统性肥大细胞增多症。当前诊断与治疗方法综述]
Recenti Prog Med. 1999 Mar;90(3):169-72.
4
Mastocytosis: current concepts in diagnosis and treatment.肥大细胞增多症:诊断与治疗的当前概念
Ann Hematol. 2002 Dec;81(12):677-90. doi: 10.1007/s00277-002-0575-z. Epub 2002 Nov 29.
5
Pediatric Mastocytosis: An Update.儿童肥大细胞增多症:最新进展
Mediterr J Hematol Infect Dis. 2021 Nov 1;13(1):e2021069. doi: 10.4084/MJHID.2021.069. eCollection 2021.
6
Mastocytosis: state of the art.肥大细胞增多症:最新进展
Pathobiology. 2007;74(2):121-32. doi: 10.1159/000101711.
7
[Guidelines for the diagnosis, treatment and management of mastocytosis].[肥大细胞增多症的诊断、治疗及管理指南]
An Sist Sanit Navar. 2008 Jan-Apr;31(1):11-32.
8
Biology, classification and treatment of human mastocytosis.人类肥大细胞增多症的生物学、分类及治疗
Wien Klin Wochenschr. 1996;108(13):385-97.
9
Update on Mastocytosis (Part 2): Categories, Prognosis, and Treatment.肥大细胞增多症最新进展(第二部分):分类、预后及治疗
Actas Dermosifiliogr. 2016 Jan-Feb;107(1):15-22. doi: 10.1016/j.ad.2015.09.009. Epub 2015 Oct 30.
10
[Mastocytosis--diagnostic criteria and treatment].[肥大细胞增多症——诊断标准与治疗]
Postepy Hig Med Dosw (Online). 2009 Nov 26;63:564-76.

引用本文的文献

1
Review and Updates on Systemic Mastocytosis and Related Entities.系统性肥大细胞增多症及相关疾病的综述与更新
Cancers (Basel). 2023 Nov 28;15(23):5626. doi: 10.3390/cancers15235626.
2
Clinical challenge for gastroenterologists-Gastrointestinal manifestations of systemic mastocytosis: A comprehensive review.内科医生面临的临床挑战-全身性肥大细胞增多症的胃肠道表现:全面综述。
World J Gastroenterol. 2022 Aug 7;28(29):3767-3779. doi: 10.3748/wjg.v28.i29.3767.
3
Cutaneous mastocytosis in childhood.儿童皮肤肥大细胞增多症。

本文引用的文献

1
Pathogenesis, classification and treatment of mastocytosis: state of the art in 2010 and future perspectives.肥大细胞病的发病机制、分类和治疗:2010 年的最新进展和未来展望。
Expert Rev Hematol. 2010 Aug;3(4):497-516. doi: 10.1586/ehm.10.42.
2
Variable presence of KITD816V in clonal haematological non-mast cell lineage diseases associated with systemic mastocytosis (SM-AHNMD).与系统性肥大细胞增多症(SM-AHNMD)相关的克隆性血液非肥大细胞谱系疾病中 KITD816V 的可变存在。
J Pathol. 2010 Apr;220(5):586-95. doi: 10.1002/path.2677.
3
Pediatric mastocytosis is a clonal disease associated with D816V and other activating c-KIT mutations.
Allergol Select. 2022 Jan 5;6:1-10. doi: 10.5414/ALX02304E. eCollection 2022.
4
Modulation of dermal equivalent of hypothalamus-pituitary-adrenal axis in mastocytosis.肥大细胞增多症中下丘脑 - 垂体 - 肾上腺轴皮肤等效物的调节
Postepy Dermatol Alergol. 2021 Jun;38(3):461-472. doi: 10.5114/ada.2021.107933. Epub 2021 Jul 26.
5
New Insights into the Pathogenesis of Systemic Mastocytosis.全身性肥大细胞增多症发病机制的新见解。
Int J Mol Sci. 2021 May 5;22(9):4900. doi: 10.3390/ijms22094900.
6
Proceedings from the Inaugural American Initiative in Mast Cell Diseases (AIM) Investigator Conference.首届美国肥大细胞疾病倡议(AIM)研究者会议论文集。
J Allergy Clin Immunol. 2021 Jun;147(6):2043-2052. doi: 10.1016/j.jaci.2021.03.008. Epub 2021 Mar 11.
7
Clinical Impact of Inherited and Acquired Genetic Variants in Mastocytosis.肥大细胞增多症中遗传和获得性基因突变的临床影响。
Int J Mol Sci. 2021 Jan 2;22(1):411. doi: 10.3390/ijms22010411.
8
Sclerotic bone lesions caused by non-infectious and non-neoplastic diseases: a review of the imaging and clinicopathologic findings.非感染性和非肿瘤性疾病所致的硬化性骨病变:影像学和临床病理表现的综述。
Skeletal Radiol. 2021 May;50(5):847-869. doi: 10.1007/s00256-020-03644-0. Epub 2020 Oct 11.
9
The role of regulatory T cells and genes involved in their differentiation in pathogenesis of selected inflammatory and neoplastic skin diseases. Part II: The Treg role in skin diseases pathogenesis.调节性T细胞及其分化相关基因在特定炎症性和肿瘤性皮肤病发病机制中的作用。第二部分:调节性T细胞在皮肤病发病机制中的作用。
Postepy Dermatol Alergol. 2017 Oct;34(5):405-417. doi: 10.5114/ada.2017.71105. Epub 2017 Oct 31.
10
The role of serum tryptase in the diagnosis and monitoring of pediatric mastocytosis: a single-center experience.血清类胰蛋白酶在儿童肥大细胞增多症诊断和监测中的作用:单中心经验
Postepy Dermatol Alergol. 2017 Aug;34(4):306-312. doi: 10.5114/ada.2017.69308. Epub 2017 Aug 1.
儿童肥大细胞增生症是一种与 D816V 和其他激活 c-KIT 突变相关的克隆性疾病。
J Invest Dermatol. 2010 Mar;130(3):804-15. doi: 10.1038/jid.2009.281. Epub 2009 Oct 29.
4
Identification of proapoptotic Bim as a tumor suppressor in neoplastic mast cells: role of KIT D816V and effects of various targeted drugs.鉴定促凋亡蛋白 Bim 作为致瘤性肥大细胞中的肿瘤抑制因子:KIT D816V 的作用以及各种靶向药物的影响。
Blood. 2009 Dec 17;114(26):5342-51. doi: 10.1182/blood-2008-08-175190. Epub 2009 Oct 22.
5
Clinical aspects of diffuse cutaneous mastocytosis in children: two variants.儿童弥漫性皮肤肥大细胞增多症的临床特点:两种变异型。
Dermatology. 2009;219(4):309-15. doi: 10.1159/000243808. Epub 2009 Oct 1.
6
Effects of topical treatment with the raft modulator miltefosine and clobetasol in cutaneous mastocytosis: a randomized, double-blind, placebo-controlled trial.米替福新和氯倍他索乳膏外用治疗皮肤肥大细胞增多症的疗效:一项随机、双盲、安慰剂对照试验。
Br J Dermatol. 2010 Jan;162(1):185-90. doi: 10.1111/j.1365-2133.2009.09434.x. Epub 2009 Aug 3.
7
Mastocytosis: an unusual clonal disorder of bone marrow-derived hematopoietic progenitor cells.肥大细胞增多症:一种源自骨髓造血祖细胞的罕见克隆性疾病。
Am J Clin Pathol. 2009 Sep;132(3):438-47. doi: 10.1309/AJCPPXHMN5CJOXHZ.
8
Mastocytosis and insect venom allergy: diagnosis, safety and efficacy of venom immunotherapy.肥大细胞增多症和昆虫毒液过敏:毒液免疫治疗的诊断、安全性和疗效。
Allergy. 2009 Sep;64(9):1237-45. doi: 10.1111/j.1398-9995.2009.02118.x. Epub 2009 Jul 21.
9
Mastocytosis: a disease of the hematopoietic stem cell.肥大细胞病:造血干细胞疾病。
Dtsch Arztebl Int. 2008 Oct;105(40):686-92. doi: 10.3238/arztebl.2008.0686. Epub 2008 Oct 3.
10
Interleukin-13 promoter gene polymorphism -1112C/T is associated with the systemic form of mastocytosis.白细胞介素-13启动子基因多态性-1112C/T与系统性肥大细胞增多症相关。
Allergy. 2009 Feb;64(2):287-94. doi: 10.1111/j.1398-9995.2008.01827.x.